Még nem toboroz
A Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL-M07D1) vs. Platinum-based Chemotherapy in Patients with HER2-expressing metastatic urothelial cancer with disease progression on or after anti-PD-(L)1-based therapy
2026-527617-29-00· 3. fázis· Systimmune Inc.· Forrás
Toboroz
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993· 3. fázis· AstraZeneca· Forrás
Toboroz
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
2024-519638-22-00· 3. fázis· Novartis Pharma AG· Forrás
Még nem toboroz
A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
2025-524160-38-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995· 3. fázis· BioNTech SE· Forrás
Toboroz
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890· University Medical Center Groningen· Forrás
Toboroz
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
2022-500676-59-00· 2. fázis· GPOH gGmbH· Forrás
Fut, nem toboroz
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás
Fut, nem toboroz
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
NCT07015983· 2. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás
Toboroz
A First-in-Human phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of [177Lu]Lu-ABY-271 in tumors and critical organs in subjects with HER2-positive metastatic breast cancer
2024-518360-13-00· 1. fázis· Affibody AB· Forrás
Toboroz
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993· 2. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806· 1. fázis· AstraZeneca· Forrás
Toboroz
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
NCT06806033· 2. fázis· Hoffmann-La Roche· Forrás
Toboroz
Cyclosporine In Takotsubo Syndrome
NCT05946772· 2. fázis· University Hospital Heidelberg· Forrás
Toboroz
Colorectal Resections in Patients With Retroperitoneal Sarcoma
NCT06943612· Heidelberg University· Forrás
Toboroz
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
NCT06780150· Hoffmann-La Roche· Forrás
Fut, nem toboroz
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
NCT06193889· 2/3. fázis· Kyverna Therapeutics· Forrás
Toboroz
Patient- and care-related benefits of amyloid PET imaging (ENABLE)
2023-503705-10-00· 4. fázis· Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.· Forrás
Toboroz
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
Next-Generation-Sequencing Approach to Neutropenic Sepsis
NCT05815628· Boris Böll· Forrás
Toboroz
PROCARE - PROstate Cancer Real World Evidence Registry
NCT06835218· UroTrials Company (GmbH)· Forrás
Toboroz
Study on the effect of 2 immunotherapy drugs in combination with radioactive glass spheres on the survival in liver cancer
2024-515127-11-00· 2. fázis· Klinikum der Universitaet Muenchen AöR· Forrás
Toboroz
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomized phase III trial - PRIMA-CNS
2024-512320-11-00· 3. fázis· Medical Center - University Of Freiburg· Forrás
Fut, nem toboroz
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients
NCT05676203· 3. fázis· Jena University Hospital· Forrás
Toboroz
DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device
NCT05543447· Acandis GmbH· Forrás
Fut, nem toboroz
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
NCT05452213· 4. fázis· Institut Für Frauengesundheit GmbH· Forrás
Toboroz
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
NCT05009082· 3. fázis· AGO Study Group· Forrás
Fut, nem toboroz
A phase II, open-label, single arm study to evaluate the efficacy of
Luspatercept in Erythropoiesis-stimulating agent naive lower-risk
MDS patients with or without ring sideroblasts who do not require
RBC transfusions
2024-516438-36-00· 2. fázis· Universitaet Leipzig· Forrás
Toboroz
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
2022-501180-40-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
NCT05197192· 3. fázis· German CLL Study Group· Forrás
Fut, nem toboroz
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836· AbbVie· Forrás
Toboroz
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
NCT04557462· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin
NCT04960709· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and total drug dose in comparison to the standard induction therapy and both treatments followed by a high dose therapy with autologous stem cell transplantation. The therapy is for patients with newly diagnosed primary lymphoma of the central nervous system.
NCT04931368· 3. fázis· Klinikum Der Landeshauptstadt Stuttgart gKAöR· Forrás
Fut, nem toboroz
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
NCT04824092· 3. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients
NCT04246684· 3. fázis· Prof. Dr. med. Claus Rödel· Forrás
Fut, nem toboroz
Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes
NCT04398654· IHF GmbH - Institut für Herzinfarktforschung· Forrás
Toboroz
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
2022-501456-28-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
NCT04298723· Jena University Hospital· Forrás
Fut, nem toboroz
A randomized, 2-arm non-comparative phase II study on the efficacy of atezolizumab and Roche bevacizumab (Atezo/Bev) followed by on-demand selective TACE (sdTACE) upon detection of disease progression or of initial synchronous treatment with TACE and Atezo/Bev on objective response rate in the treatment of unresectable hepatocellular carcinoma patients (DEMAND)
NCT04224636· 2. fázis· Klinikum der Universitaet Muenchen AöR· Forrás
Toboroz
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
2022-501454-11-00· 3. fázis· GPOH gGmbH· Forrás
Fut, nem toboroz
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
NCT04230759· 2. fázis· Goethe University· Forrás
Fut, nem toboroz
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
NCT03897127· 3. fázis· University of Ulm· Forrás
Toboroz
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494· 3. fázis· University Hospital Muenster· Forrás
Fut, nem toboroz
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours
2023-507582-25-00· 3. fázis· Rheinische Friedrich-Wilhelms-Universitaet Bonn· Forrás
Showing 50 of 62.